Publicacións (59) Publicacións de PEDRO JOSÉ REAL LUNA

2024

  1. Potential clinical applications of extracellular vesicles in pancreatic cancer: exploring untapped opportunities from biomarkers to novel therapeutic approaches

    Extracellular Vesicles and Circulating Nucleic Acids, Vol. 5, Núm. 2, pp. 180-200

2023

  1. Lentiviral gene therapy reverts GPIX expression and phenotype in Bernard-Soulier syndrome type C

    Molecular Therapy - Nucleic Acids, Vol. 33, pp. 75-92

  2. The pediatric leukemia oncoprotein NUP98-KDM5A induces genomic instability that may facilitate malignant transformation

    Cell Death and Disease, Vol. 14, Núm. 6

2022

  1. Characterization of Genetic Variants of Uncertain Significance for the ALPL Gene in Patients With Adult Hypophosphatasia

    Frontiers in Endocrinology, Vol. 13

  2. Exchange of cellular components between platelets and tumor cells: impact on tumor cells behavior

    Theranostics, Vol. 12, Núm. 5, pp. 2150-2161

  3. Generation of a H9 Clonal Cell Line With Inducible Expression of NUP98-KDM5A Fusion Gene in the AAVS1 Safe Harbor Locus

    Frontiers in Cell and Developmental Biology, Vol. 10

  4. Proximity labeling identifies a repertoire of site-specific R-loop modulators

    Nature Communications, Vol. 13, Núm. 1

2021

  1. Cross‐resistance to abiraterone and enzalutamide in castration resistance prostate cancer cellular models is mediated by ar transcriptional reactivation

    Cancers, Vol. 13, Núm. 6, pp. 1-21

  2. Improved functionality of integration-deficient lentiviral vectors (IDLVs) by the inclusion of IS2 protein docks

    Pharmaceutics, Vol. 13, Núm. 8

2019

  1. Cellular and animal models of skin alterations in the autism-related ADNP syndrome

    Scientific Reports, Vol. 9, Núm. 1

  2. Enhanced hemato-endothelial specification during human embryonic differentiation through developmental cooperation between AF4-MLL and MLL-AF4 fusions

    Haematologica, Vol. 104, Núm. 6, pp. 1189-1201

  3. Epidemiological, Clinical and Genetic Study of Hypophosphatasia in A Spanish Population: Identification of Two Novel Mutations in The Alpl Gene

    Scientific Reports, Vol. 9, Núm. 1

  4. GENYOi004-A: An induced pluripotent stem cells (iPSCs)line generated from a patient with autism-related ADNP syndrome carrying a pTyr719* mutation

    Stem Cell Research, Vol. 37

  5. GENYOi005-A: An induced pluripotent stem cells (iPSCs) line generated from a patient with Familial Platelet Disorder with associated Myeloid Malignancy (FPDMM) carrying a p.Thr196Ala variant

    Stem Cell Research, Vol. 41

2018

  1. The IS2 Element Improves Transcription Efficiency of Integration-Deficient Lentiviral Vector Episomes

    Molecular Therapy - Nucleic Acids, Vol. 13, pp. 16-28

2017

  1. Induced pluripotent stem cells derived from Bernard-Soulier Syndrome patient's peripheral blood cells with a p.Phe55Ser mutation in the GPIX gene

    Stem Cell Research, Vol. 20, pp. 10-13

  2. Poly(ethylmethacrylate-co-diethylaminoethyl acrylate) coating improves endothelial re-population, bio-mechanical and anti-thrombogenic properties of decellularized carotid arteries for blood vessel replacement

    Scientific Reports, Vol. 7, Núm. 1

  3. RUNX1c Regulates Hematopoietic Differentiation of Human Pluripotent Stem Cells Possibly in Cooperation with Proinflammatory Signaling

    Stem Cells, Vol. 35, Núm. 11, pp. 2253-2266

2016

  1. Absence of WASp enhances hematopoietic and megakaryocytic differentiation in a human embryonic stem cell model

    Molecular Therapy, Vol. 24, Núm. 2, pp. 342-353

  2. Erratum: Corrigendum to “Generation of induced pluripotent stem cells (iPSCs) from a Bernard-Soulier syndrome patient carrying a W71R mutation in the GPIX gene” (Stem Cell Research (2016) 16(3) (692–695) (S1873506116300253) (10.1016/j.scr.2016.04.013))

    Stem Cell Research